Orchid Pharma informs about company updates

11 Apr 2016 Evaluate

Orchid Pharma has informed that Orchid received the Establishment inspection report (EIR) from USFDA based on the successful inspection closure for the API manufacturing facility located at Alathur, Kancheepuram District, India. The facility was inspected by USFDA in the month of August 2015.

The above information is a part of company’s filings submitted to BSE.

Orchid Pharma Share Price

645.85 -19.40 (-2.92%)
24-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1730.55
Dr. Reddys Lab 1299.40
Cipla 1326.30
Zydus Lifesciences 904.35
Lupin 2251.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×